JP2016511406A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511406A5
JP2016511406A5 JP2015560663A JP2015560663A JP2016511406A5 JP 2016511406 A5 JP2016511406 A5 JP 2016511406A5 JP 2015560663 A JP2015560663 A JP 2015560663A JP 2015560663 A JP2015560663 A JP 2015560663A JP 2016511406 A5 JP2016511406 A5 JP 2016511406A5
Authority
JP
Japan
Prior art keywords
complement
apolipoprotein
igg
binding protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015560663A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016511406A (ja
JP6430413B2 (ja
Filing date
Publication date
Priority claimed from GB1303936.7A external-priority patent/GB2511525A/en
Application filed filed Critical
Publication of JP2016511406A publication Critical patent/JP2016511406A/ja
Publication of JP2016511406A5 publication Critical patent/JP2016511406A5/ja
Application granted granted Critical
Publication of JP6430413B2 publication Critical patent/JP6430413B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2015560663A 2013-03-05 2014-03-04 アルツハイマー病の診断のための方法と組成物 Active JP6430413B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1303936.7A GB2511525A (en) 2013-03-05 2013-03-05 Methods and Compositions for the Diagnosis of Alzheimer's Disease
GB1303936.7 2013-03-05
PCT/EP2014/054185 WO2014135546A1 (en) 2013-03-05 2014-03-04 Methods and compositions for the diagnosis of alzheimer's disease

Publications (3)

Publication Number Publication Date
JP2016511406A JP2016511406A (ja) 2016-04-14
JP2016511406A5 true JP2016511406A5 (enExample) 2017-04-13
JP6430413B2 JP6430413B2 (ja) 2018-11-28

Family

ID=48142456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015560663A Active JP6430413B2 (ja) 2013-03-05 2014-03-04 アルツハイマー病の診断のための方法と組成物

Country Status (9)

Country Link
US (1) US20160097780A1 (enExample)
EP (1) EP2965090B1 (enExample)
JP (1) JP6430413B2 (enExample)
CN (1) CN105164536B (enExample)
AU (1) AU2014224727B2 (enExample)
CA (1) CA2900002C (enExample)
ES (1) ES2674526T3 (enExample)
GB (1) GB2511525A (enExample)
WO (1) WO2014135546A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201504432D0 (en) * 2015-03-17 2015-04-29 Electrophoretics Ltd Materials and methods for diagnosis and treatment of alzheimers disease
JP6702836B2 (ja) * 2016-09-28 2020-06-03 ハルメク・ベンチャーズ株式会社 認知症判定得点算出装置及びそのプログラム
EP3309550A1 (en) * 2016-10-12 2018-04-18 sphingotec GmbH Method for the detection of apolipoprotein e4
CN111247595B (zh) 2017-10-31 2024-07-23 通用电气健康护理有限公司 用于诊断认知疾病病理和/或结果的医疗系统
JP6950952B2 (ja) * 2017-12-20 2021-10-13 国立大学法人三重大学 脳アミロイド血管症の末梢血バイオマーカー
CN108681748A (zh) * 2018-05-18 2018-10-19 宝枫生物科技（北京）有限公司 判别轻度认知障碍的模型选择处理方法及装置
BR112021000895A2 (pt) * 2018-07-19 2021-04-13 Genentech, Inc. Métodos para identificar um indivíduo como possuindo ou estando em risco de desenvolver uma demência positiva para amilóide e para detectar um indivíduo com um valor aumentado para uma combinação de marcadores e uso de ass40, ass42 e ttau
CN110464833A (zh) * 2019-09-04 2019-11-19 北京豪思生物科技有限公司 铜蓝蛋白的应用
WO2021071219A1 (ko) * 2019-10-07 2021-04-15 조한나 퇴행성 신경질환의 진단용 바이오마커
JP7109499B2 (ja) * 2020-05-07 2022-07-29 一般社団法人脳と心の健康科学研究所 認知症判定得点算出装置及びそのプログラム
US20240077501A1 (en) * 2020-12-28 2024-03-07 Mcbi Inc. Judgment supporting information generating method, judgment supporting information generating system, and information processing device
ES2924776A1 (es) * 2021-03-25 2022-10-10 Univ Castilla La Mancha Metodos para el diagnostico y pronostico de la enfermedad de alzheimer
CN112858697B (zh) * 2021-03-29 2024-03-01 鲁东大学 ALG-2-interacting protein X在制备分子标志物中的应用
CN114634970A (zh) * 2022-03-29 2022-06-17 南通惠皓医疗科技有限公司 遗传性阿尔兹海默症致病基因panel检测方法
CN116990395A (zh) * 2022-04-26 2023-11-03 中国科学院深圳先进技术研究院 一种基于粪便的阿尔兹海默症生物标志物及其应用
EP4549945A1 (en) * 2022-06-28 2025-05-07 Mcbi Inc. Assessment-supporting information generating method, assessment-supporting information generating system, and information processing device
CN116063447B (zh) * 2022-09-13 2023-11-03 北京湃德智健科技有限公司 用于检测adap自身抗体的抗原多肽及其应用
CN119495355B (zh) * 2024-10-31 2026-04-24 山东大学 一种阿尔兹海默症诊断标志物的筛选方法和系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH067191A (ja) * 1991-09-26 1994-01-18 Konica Corp モノクローナル抗体、それを産生するハイブリド−マ、その対応抗原及びそれを用いた測定方法
US5652352A (en) * 1994-03-31 1997-07-29 Amgen Inc. Afamin: a human serum albumin-like gene
AT411014B (de) * 2001-04-30 2003-09-25 Vitateq Biotechnology Gmbh Präparationen von vitamin e in kombination mit afamin
JP4153873B2 (ja) * 2001-10-04 2008-09-24 株式会社 免疫生物研究所 アルツハイマー危険因子の検出試薬および検出用キットならびにこれらを用いるアルツハイマー危険因子の検出方法
WO2005107760A1 (en) * 2004-04-30 2005-11-17 Irm Llc Compounds and compositions as inducers of keratinocyte differentiation
WO2006108051A2 (en) * 2005-04-05 2006-10-12 Neurodx, Llc Compositions and methods relating to alzheimer's disease
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
US7575876B2 (en) * 2005-10-27 2009-08-18 The University Of Washington Biomarkers for neurodegenerative disorders
AT505727B1 (de) * 2007-09-04 2009-06-15 Univ Innsbruck Verfahren zur diagnose des metabolischen syndroms
GB0921447D0 (en) * 2009-12-04 2010-01-20 Randox Lab Ltd Assay
EP2569451A4 (en) * 2010-05-14 2013-09-11 Rules Based Medicine Inc METHOD AND DEVICES FOR DIAGNOSING MORBUS ALZHEIMER
NZ629074A (en) * 2012-01-20 2016-09-30 Adelaide Res & Innovation Pty Biomarkers for gastric cancer and uses thereof
ITMI20120865A1 (it) * 2012-05-18 2013-11-19 Antonio Bertolotto Biomarcatori per patologie del sistema nervoso centrale

Similar Documents

Publication Publication Date Title
JP6430413B2 (ja) アルツハイマー病の診断のための方法と組成物
Niethamer et al. Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury
Falcon et al. CCR5 deficiency predisposes to fatal outcome in influenza virus infection
JP7458678B2 (ja) タンパク質同定のためのデコーディングアプローチ方法
Hackl et al. Computational genomics tools for dissecting tumour–immune cell interactions
JP5749156B2 (ja) 生理活性物質の生産のための単一細胞を選抜する方法
CA3050109A1 (en) Neoantigens and uses thereof for treating cancer
JP2017532633A5 (enExample)
McArdle et al. Discovery proteomics for COVID-19: where we are now
JP2017503473A5 (enExample)
Rahim et al. Generation and characterization of a new panel of broadly reactive anti-NS1 mAbs for detection of influenza A virus
Min et al. Multiple Orientia tsutsugamushi ankyrin repeat proteins interact with SCF1 ubiquitin ligase complex and eukaryotic elongation factor 1 α
RU2018120081A (ru) Способы детекции аполипопротеинов
Kano et al. The presence, persistence and functional properties of Plasmodium vivax duffy binding protein II antibodies are influenced by HLA class II allelic variants
Kesarwani et al. Identification of unique peptides for SARS-CoV-2 diagnostics and vaccine development by an in silico proteomics approach
JP2016526167A5 (enExample)
Zainulabid et al. Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B. 1.524 and AU. 2 in Malaysia
Costa et al. Evaluation and comparison of the ability of online available prediction programs to predict true linear B-cell epitopes
Gao et al. MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine production
Mielcarska et al. Prognostic significance of B7H3 expression in solid tumors: a systematic review and meta-analysis
JP2021501601A5 (enExample)
Ponasenko et al. Polymorphisms within innate immune response, calcium metabolism and lipid metabolism are predictors of infective endocarditis
US11952631B2 (en) Diagnostics and therapy for human respiratory syncytial virus
Upton et al. Epistatic analysis of Clarkson disease
KR102956551B1 (ko) 신생항원 마커 및 글로벌 dna 메틸화 마커를 이용한 면역항암제에 대한 치료 반응성 예측 방법 및 장치